Literature DB >> 26672781

Screening: Diagnostic dilemma.

Emily Sohn.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26672781     DOI： 10.1038/528S120a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.

Authors:  Diane Goltz; Heidrun Gevensleben; Jörn Dietrich; Jörg Ellinger; Jennifer Landsberg; Glen Kristiansen; Dimo Dietrich
Journal:  Oncoimmunology       Date:  2016-09-02       Impact factor: 8.110

2.  Optimization of ZD2 Peptide Targeted Gd(HP-DO3A) for Detection and Risk-Stratification of Prostate Cancer with MRI.

Authors:  Nadia R Ayat; Jing-Can Qin; Han Cheng; Sarah Roelle; Songqi Gao; Yajuan Li; Zheng-Rong Lu
Journal:  ACS Med Chem Lett       Date:  2018-06-06       Impact factor: 4.345

3.  Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids.

Authors:  Matheus M Pereira; João D Calixto; Ana C A Sousa; Bruno J Pereira; Álvaro S Lima; João A P Coutinho; Mara G Freire
Journal:  Sci Rep       Date:  2020-09-10       Impact factor: 4.379

4.  PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.

Authors:  Emily Eva Holmes; Diane Goltz; Glen Kristiansen; Dimo Dietrich; Verena Sailer; Maria Jung; Sebastian Meller; Barbara Uhl; Jörn Dietrich; Magda Röhler; Jörg Ellinger
Journal:  Clin Epigenetics       Date:  2016-09-26       Impact factor: 6.551

5.  Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.

Authors:  Montserrat Ferrer-Batallé; Esther Llop; Manel Ramírez; Rosa Núria Aleixandre; Marc Saez; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

Review 6.  Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.

Authors:  Andrej Jedinak; Kevin R Loughlin; Marsha A Moses
Journal:  Oncotarget       Date:  2018-08-21

7.  Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments.

Authors:  Jinyuan Xu; Aiai Shi; Zhilin Long; Liwen Xu; Gaoming Liao; Chunyu Deng; Min Yan; Aiming Xie; Tao Luo; Jian Huang; Yun Xiao; Xia Li
Journal:  EBioMedicine       Date:  2018-09-01       Impact factor: 8.143

8.  High-Throughput, Time-Resolved Mechanical Phenotyping of Prostate Cancer Cells.

Authors:  Yuri Belotti; Serenella Tolomeo; Michael J Conneely; Tianjun Huang; Stephen J McKenna; Ghulam Nabi; David McGloin
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

9.  SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.

Authors:  Xin Li; Wanfeng Zhang; Jing Song; Xianqin Zhang; Longke Ran; Yunfeng He
Journal:  Clin Epigenetics       Date:  2019-07-09       Impact factor: 6.551

10.  'Multi-omic' data analysis using O-miner.

Authors:  Ajanthah Sangaralingam; Abu Z Dayem Ullah; Jacek Marzec; Emanuela Gadaleta; Ai Nagano; Helen Ross-Adams; Jun Wang; Nicholas R Lemoine; Claude Chelala
Journal:  Brief Bioinform       Date:  2019-01-18       Impact factor: 11.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.